Literature DB >> 23195405

Calcium channel blocking activity: Screening methods for plant derived compounds.

H Vuorela1, P Vuorela, K Törnquist, S Alaranta.   

Abstract

Calcium channel blockers are a heterogenous group of substances that inhibit influx of Ca(2+) into the cell. Their main therapeutical influence is on the function of heart and blood circulation. A vast number of pure natural compounds with calcium antagonistic activity, mainly coumarins, have been isolated from plants and identified. Screening natural products for calcium channel blockers has been done through classical in vitro aorta or ileum strip assays, but recently in vitro screens using animal cell lines also have been established. The number of in vivo assays on natural compounds is quite limited so far. Much more research is needed to clarify the basic pharmacology and to determine the possible clinical use of pure compounds discovered from plants.
Copyright © 1997 Gustav Fischer Verlag. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Year:  1997        PMID: 23195405     DOI: 10.1016/S0944-7113(97)80064-5

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  3 in total

1.  Abutilon theophrasti's defense against the allelochemical benzoxazolin-2(3H)-one: support by Actinomucor elegans.

Authors:  Sevda Haghi Kia; Margot Schulz; Emmanuel Ayah; Alexander Schouten; Carmen Müllenborn; Christian Paetz; Bernd Schneider; Diana Hofmann; Ulrich Disko; Vincenzo Tabaglio; Adriano Marocco
Journal:  J Chem Ecol       Date:  2014-11-29       Impact factor: 2.626

2.  Herbicidal properties of antihypertensive drugs: calcium channel blockers.

Authors:  Hannan Safiyyah Tan Sian Hui Abdullah; Poh Wai Chia; Dzolkhifli Omar; Tse Seng Chuah
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

3.  Extracts and Fractions from Edible Roots of Sechium edule (Jacq.) Sw. with Antihypertensive Activity.

Authors:  Galia Lombardo-Earl; Rubén Roman-Ramos; Alejandro Zamilpa; Maribel Herrera-Ruiz; Gabriela Rosas-Salgado; Jaime Tortoriello; Enrique Jiménez-Ferrer
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-09       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.